Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/CSP-2503> ?p ?o }
Showing triples 1 to 82 of
82
with 100 triples per page.
- CSP-2503 abstract "CSP-2503 is a potent and selective 5-HT1A receptor agonist, 5-HT2A receptor antagonist, and 5-HT3 receptor antagonist of the phenylpiperazine class. First synthesized in 2003, it was designed based on computational models and QSAR studies. In rat studies, CSP-2503 has demonstrated anxiolytic effects, and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.".
- CSP-2503 atcPrefix "none".
- CSP-2503 iupacName "2-[(4-naphthalen-1-ylpiperazin-1-yl)methyl]hexahydropyrrolo[1,2-a]pyrazine-1,4-dione".
- CSP-2503 pubchem "10317515".
- CSP-2503 thumbnail CSP-2503-structure.png?width=300.
- CSP-2503 wikiPageID "28480622".
- CSP-2503 wikiPageLength "3712".
- CSP-2503 wikiPageOutDegree "20".
- CSP-2503 wikiPageRevisionID "659859980".
- CSP-2503 wikiPageWikiLink 5-HT1A_receptor.
- CSP-2503 wikiPageWikiLink 5-HT2A_receptor.
- CSP-2503 wikiPageWikiLink 5-HT3_receptor.
- CSP-2503 wikiPageWikiLink Agonist.
- CSP-2503 wikiPageWikiLink Anxiety.
- CSP-2503 wikiPageWikiLink Anxiolytic.
- CSP-2503 wikiPageWikiLink Binding_selectivity.
- CSP-2503 wikiPageWikiLink Category:Diketopiperazines.
- CSP-2503 wikiPageWikiLink Category:Lactams.
- CSP-2503 wikiPageWikiLink Category:Naphthalenes.
- CSP-2503 wikiPageWikiLink Category:Pyrrolopyrazines.
- CSP-2503 wikiPageWikiLink Chemical_synthesis.
- CSP-2503 wikiPageWikiLink Computational_model.
- CSP-2503 wikiPageWikiLink Mechanism_of_action.
- CSP-2503 wikiPageWikiLink Naphthylpiperazine.
- CSP-2503 wikiPageWikiLink Phenylpiperazine.
- CSP-2503 wikiPageWikiLink Potency_(pharmacology).
- CSP-2503 wikiPageWikiLink Quantitative_structure-activity_relationship.
- CSP-2503 wikiPageWikiLink Quantitative_structure–activity_relationship.
- CSP-2503 wikiPageWikiLink Receptor_antagonist.
- CSP-2503 wikiPageWikiLink S-14,671.
- CSP-2503 wikiPageWikiLink S-14671.
- CSP-2503 wikiPageWikiLinkText "CSP-2503".
- CSP-2503 atcPrefix "none".
- CSP-2503 c "22".
- CSP-2503 chembl "285066".
- CSP-2503 chemspiderid "8492979".
- CSP-2503 h "26".
- CSP-2503 hasPhotoCollection CSP-2503.
- CSP-2503 inchi "1".
- CSP-2503 inchikey "CTZWGZSINBFHFD-UHFFFAOYAW".
- CSP-2503 iupacName "2".
- CSP-2503 molecularWeight "378.47".
- CSP-2503 n "4".
- CSP-2503 o "2".
- CSP-2503 pubchem "10317515".
- CSP-2503 smiles "O=C4N5CCCC5CNC4".
- CSP-2503 stdinchi "1".
- CSP-2503 stdinchikey "CTZWGZSINBFHFD-UHFFFAOYSA-N".
- CSP-2503 verifiedrevid "414040667".
- CSP-2503 wikiPageUsesTemplate Template:Anxiolytics.
- CSP-2503 wikiPageUsesTemplate Template:Drugbox.
- CSP-2503 wikiPageUsesTemplate Template:Piperazines.
- CSP-2503 wikiPageUsesTemplate Template:Reflist.
- CSP-2503 wikiPageUsesTemplate Template:Serotonergics.
- CSP-2503 subject Category:Diketopiperazines.
- CSP-2503 subject Category:Lactams.
- CSP-2503 subject Category:Naphthalenes.
- CSP-2503 subject Category:Pyrrolopyrazines.
- CSP-2503 hypernym HT.
- CSP-2503 type Article.
- CSP-2503 type ChemicalSubstance.
- CSP-2503 type Drug.
- CSP-2503 type Acene.
- CSP-2503 type Amide.
- CSP-2503 type Article.
- CSP-2503 type Chemical.
- CSP-2503 type Drug.
- CSP-2503 type Heterocycle.
- CSP-2503 type Lactam.
- CSP-2503 type ChemicalObject.
- CSP-2503 type Thing.
- CSP-2503 type Q8386.
- CSP-2503 comment "CSP-2503 is a potent and selective 5-HT1A receptor agonist, 5-HT2A receptor antagonist, and 5-HT3 receptor antagonist of the phenylpiperazine class. First synthesized in 2003, it was designed based on computational models and QSAR studies. In rat studies, CSP-2503 has demonstrated anxiolytic effects, and thus has been suggested as a treatment for anxiety in humans with a multimodal mechanism of action.".
- CSP-2503 label "CSP-2503".
- CSP-2503 sameAs m.0crgdfd.
- CSP-2503 sameAs CSP-2503.
- CSP-2503 sameAs CSP-2503.
- CSP-2503 sameAs Q12744889.
- CSP-2503 sameAs Q12744889.
- CSP-2503 wasDerivedFrom CSP-2503?oldid=659859980.
- CSP-2503 depiction CSP-2503-structure.png.
- CSP-2503 isPrimaryTopicOf CSP-2503.
